DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l72nrk/global_and) has announced the addition of the "Global and Chinese ...

Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for Trazodone Hydrochloride Tablets USP, 50 mg, 100 ...

February 11, 2010 — The US Food and Drug Administration (FDA) has approved once-daily trazodone HCl extended-release tablets (Oleptro, Labopharm, Inc) for the treatment of major depressive disorder in ...

Trazodone (multiple brands) is not associated with reduced dementia risk compared to other antidepressants, new research suggests. Investigators searched primary care electronic health records for ...

Oleptro available for major depressive disorder Labopharm and Angelini announced the launch of Oleptro (trazodone HCl extended-release tablets) for the treatment of major depressive disorder (MDD) in ...

Federal health officials are ordering makers of antidepressants to use stark new warnings alerting doctors and consumers that the medications increase the risk of suicidal thoughts and behaviors in ...

The U.S. Food and Drug Administration proposed that the labels of all antidepressant medications warn of increased risks of suicidal thoughts and behavior for young adults, ages 18 to 24. Here is the ...

Trazodone is a generic prescription drug that’s used to treat depression in adults. Trazodone’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you ...